XML 42 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Equity Incentive Plans (Tables)
12 Months Ended
Jan. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information
A summary of the stock option activity under our equity incentive plans and related information is as follows:
 
 
Options Outstanding
 
 
 
 
 
Number of
Shares
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
(in thousands)
Balance as of January 31, 2018
46,359,949

 
$
7.75

 
6.3
 
$
574,224

Options exercised
(9,397,220
)
 
5.08

 
 
 
 

Options forfeited/canceled
(1,497,186
)
 
10.55

 
 
 
 

Balance as of January 31, 2019
35,465,543

 
$
8.34

 
5.4
 
$
339,591

Vested and exercisable as of January 31, 2019
26,592,658

 
$
6.76

 
5.1
 
$
296,710

Summary of Estimate Fair Value of Employee Stock Options and Employee Purchase Plan
We estimate the fair value of employee stock options and ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions:
 
 
Year Ended January 31,
 
2017
 
2018
 
2019
Employee Stock Options
 
 
 
 
 
Expected term (in years)
6.1

 
6.1

 
n/a
Expected volatility
44
%
 
47
%
 
n/a
Risk-free interest rate
1.3% - 1.5%

 
1.9
%
 
n/a
Dividend rate

 

 
n/a
Fair value of common stock
$10.37 - $14.52

 
$12.84
 
n/a
Employee Stock Purchase Plan
 

 
 

 
 

Expected term (in years)
0.5 - 2.0

 
0.5 - 2.0

 
0.5 - 2.0

Expected volatility
41
%
 
35% - 39%

 
44% - 47%

Risk-free interest rate
0.5% - 0.9%

 
0.9% - 1.4%

 
2.0% - 2.8%

Dividend rate

 

 

Fair value of common stock
$12.36 - $13.72

 
$10.39 - $14.65

 
$20.62 - $27.66

Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of the RSU activity under our 2015 Plan and related information is as follows:
 
Number of RSUs Outstanding
 
Weighted-Average Grant Date Fair Value
 
Aggregate Intrinsic Value
(in thousands)
Unvested balance as of January 31, 2018
17,682,646

 
$
12.60

 
$
356,117

Granted
15,891,112

 
20.73

 
 
Vested
(8,403,422
)
 
13.24

 
 
Forfeited
(2,109,948
)
 
16.09

 
 
Converted
(1,142,838
)
 
11.86

 
 
Unvested balance of January 31, 2019
21,917,550

 
$
17.94

 
$
392,515

A summary of the restricted stock activity under our 2015 Plan and related information is as follows:
 
Number of Restricted Stock Outstanding
 
Weighted-
Average
Grant Date
Fair Value
 
Aggregate
Intrinsic
Value
(in thousands)
Unvested Balance as of January 31, 2018

 
$

 
$

Granted and converted
3,514,020

 
19.25

 
 
Vested
(145,232
)
 
12.84

 
 
Forfeited/canceled
(1,101,219
)
 
21.15

 
 
Unvested Balance as of January 31, 2019
2,267,569

 
$
18.70

 
$
40,612

Summarizes the Components of Stock-Based Compensation
The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands):
 
Year Ended January 31,
 
2017
 
2018
 
2019
Cost of revenue—product
$
601

 
$
1,630

 
$
2,951

Cost of revenue—support subscription
5,639

 
9,050

 
12,378

Research and development
63,495

 
71,229

 
92,484

Sales and marketing
34,317

 
47,687

 
66,350

General and administrative
12,616

 
21,077

 
36,482

Total stock-based compensation expense
$
116,668

 
$
150,673

 
$
210,645